4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000899243-24-000245
Director sold 32,489 shares at an average $252.85 ($8,214,998)
- Director acquired 32,489 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BATE KENNETH · Director
Table I: Non-derivative
21 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $9.45 | $94,500 | 11,198 | D |
| 2024-04-01 | Exercise or conversion : show line 2 in the form 10b5-1 | +10,000 | $100.45 | $1,004,500 | 21,198 | D |
| 2024-04-01 | Exercise or conversion : show line 3 in the form 10b5-1 | +1,277 | $105.08 | $134,187 | 22,475 | D |
| 2024-04-01 | Sale : show line 4 in the form 10b5-1 | −6,698 | $255.62 | $1,712,119 | 15,777 | D |
| 2024-04-01 | Sale : show line 5 in the form 10b5-1 | −7,411 | $256.49 | $1,900,850 | 8,366 | D |
| 2024-04-01 | Sale : show line 6 in the form 10b5-1 | −2,790 | $257.33 | $717,940 | 5,576 | D |
| 2024-04-01 | Sale : show line 7 in the form 10b5-1 | −2,104 | $258.24 | $543,339 | 3,472 | D |
| 2024-04-01 | Sale : show line 8 in the form 10b5-1 | −200 | $259.13 | $51,826 | 3,272 | D |
| Open-market sales · 32,489 sh · avg $252.85 · $8,214,998 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-04-01 | Exercise or conversion : show line 22 in the form 10b5-1 Stock Option (Right to Buy) | −10,000 | 10,000 | D |
| 2024-04-01 | Exercise or conversion : show line 23 in the form 10b5-1 Stock Option (Right to Buy) | −10,000 | 0 | D |
| 2024-04-01 | Exercise or conversion : show line 24 in the form 10b5-1 Stock Option (Right to Buy) | −1,277 | 11,212 | D |
| 2024-04-02 | Exercise or conversion : show line 25 in the form 10b5-1 Stock Option (Right to Buy) | −11,212 | 0 | D |
Loading xslF345X05/doc4.xml…